- Home
- EBS vs OTLY Comparison
EBS vs OTLY Comparison
Compare EBS & OTLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EBS | OTLY |
|---|---|---|
| Founded | 1998 | 1994 |
| Country | United States | Sweden |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 423.6M | 393.4M |
| IPO Year | 2006 | 2021 |
Fundamental Metrics
Financial Performance| Metric | EBS | OTLY |
|---|---|---|
| Price | $8.24 | $8.21 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 5 |
| Target Price | $12.00 | ★ $14.50 |
| AVG Volume (30 Days) | ★ 728.7K | 111.0K |
| Earning Date | 04-30-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 125.83 | N/A |
| EPS | ★ 0.07 | N/A |
| Revenue | ★ $742,900,000.00 | N/A |
| Revenue This Year | $1.29 | $7.91 |
| Revenue Next Year | N/A | $5.50 |
| P/E Ratio | $113.57 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.62 | $8.09 |
| 52 Week High | $14.06 | $18.84 |
Technical Indicators
Market Signals| Indicator | EBS | OTLY |
|---|---|---|
| Relative Strength Index (RSI) | 46.88 | 25.26 |
| Support Level | $7.76 | $8.09 |
| Resistance Level | $8.54 | $12.58 |
| Average True Range (ATR) | 0.46 | 0.43 |
| MACD | -0.06 | -0.12 |
| Stochastic Oscillator | 34.78 | 5.13 |
Price Performance
Historical ComparisonAbout EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.
About OTLY Oatly Group AB
Oatly Group AB produces and distributes oat-based food and beverage products. Its offerings include milk, cooking creams, spreads, and yogurts. The company's products are sold through retail stores, coffee shops, and restaurants across multiple countries. It generates revenue from sales of oatmilk and other oat-based products. The company's geographical segments include Europe & International, North America and Greater China. The Europe & International segment is its maximum revenue-producing segment, followed by the North America and Greater China segments.